🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kari J. Kurppa

Åbo Akademi University

ORCID: 0000-0001-8286-2429

Also affiliated with University of Turku, Turku Centre for Computer Science, Turku Centre for Biotechnology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway”.

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Cancer Cell(2020)10.1016/j.ccell.2019.12.006
N/A
0.925DataRank · unranked
477 citations

Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi +39 more

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Blood Advances(2022)10.1182/bloodadvances.2021005859
N/A
0.542DataRank · unranked
36 citations

Larisa V. Kovtonyuk, Nancy Klemm, Jonas Fullin, Sebastian M. Stolz, Jan Mueller +6 more

Good Guy in Bad Company: How STRNs Convert PP2A into an Oncoprotein

Cancer Cell(2020)10.1016/j.ccell.2020.06.011
N/A
0.396DataRank · unranked
13 citations

Jukka Westermarck, Kari J. Kurppa

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Nature Cancer(2022)10.1038/s43018-022-00351-8
N/A
0DataRank · unranked
163 citations

Tyler S. Beyett, Jaebong Jang, William W. Feng, Magda Bahcall, Heidi M. Haikala +21 more

Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors

Nature Communications(2022)10.1038/s41467-022-33210-2
N/A
0DataRank · unranked
28 citations

Geoffrey R. Oxnard, Elizabeth F. Cohen, Navin R. Mahadevan, Joao V. Alessi, Yin P. Hung +18 more

The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect

Cancer Research(2025)10.1158/0008-5472.can-24-1136
N/A
0DataRank · unranked
4 citations

Roman R. Schimmer, Nils K. Konrad, Flavian Thelen, Jonas Fullin, Ebru Topçu +17 more